Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration ... more options and greater ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ... Impairment and Dementia Dec. 18 ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...